Date published: 2025-10-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

C1orf80 Inhibitors

C1orf80 inhibitors would denote a group of chemical compounds specifically designed to inhibit the function of a protein encoded by the C1orf80 gene-a gene named for its location on chromosome 1 and its initial characterization as an open reading frame (orf). The C1orf80 gene product is a protein whose function might not be well-understood or characterized, as is often the case with proteins labeled in this fashion. If research has revealed a particular cellular or biochemical function for the C1orf80 protein, such as involvement in a signaling pathway or regulation of gene expression, inhibitors of this protein could be synthesized to study this function in greater detail. The development of C1orf80 inhibitors would provide researchers with a tool to modulate the protein's activity in vitro and in vivo, allowing for a deeper investigation into the biological processes in which C1orf80 plays a part.

The process of identifying and creating C1orf80 inhibitors would typically start with the elucidation of the protein's structure and mechanism of action. Detailed studies to understand the topology, domain structure, and active or binding sites of the C1orf80 protein would be fundamental. Techniques such as X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, or cryo-electron microscopy could be employed to determine the three-dimensional conformation of the protein at high resolution. Concurrently, functional assays could be utilized to decipher the role of C1orf80 at the molecular level, such as its interaction with other proteins, DNA, or small molecules. This knowledge is crucial for the rational design of small molecules or peptides that could interact with the C1orf80 protein and inhibit its function.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Quercetin

117-39-5sc-206089
sc-206089A
sc-206089E
sc-206089C
sc-206089D
sc-206089B
100 mg
500 mg
100 g
250 g
1 kg
25 g
$11.00
$17.00
$108.00
$245.00
$918.00
$49.00
33
(2)

Quercetin is known to inhibit kinase activity and could potentially interfere with the Wnt/β-catenin pathway, affecting AIDA expression indirectly.

Niclosamide

50-65-7sc-250564
sc-250564A
sc-250564B
sc-250564C
sc-250564D
sc-250564E
100 mg
1 g
10 g
100 g
1 kg
5 kg
$37.00
$77.00
$184.00
$510.00
$1224.00
$5814.00
8
(1)

An antihelminthic that can also inhibit the Wnt/β-catenin signaling pathway, possibly affecting AIDA expression.

IWR-1-endo

1127442-82-3sc-295215
sc-295215A
5 mg
10 mg
$82.00
$132.00
19
(1)

IWR-1 is a Wnt pathway inhibitor, acting to stabilize axin and prevent Wnt pathway activation, which could downregulate AIDA expression.

XAV939

284028-89-3sc-296704
sc-296704A
sc-296704B
1 mg
5 mg
50 mg
$35.00
$115.00
$515.00
26
(1)

XAV-939 stimulates β-catenin degradation by stabilizing axin, potentially decreasing AIDA expression as a downstream effect.

JW 55

664993-53-7sc-364517
sc-364517A
10 mg
50 mg
$172.00
$726.00
(0)

JW55 antagonizes the Wnt/β-catenin signal by enhancing β-catenin degradation, which could lead to reduced AIDA expression.

β-Catenin/Tcf Inhibitor, FH535

108409-83-2sc-221398
sc-221398A
10 mg
50 mg
$178.00
$367.00
7
(1)

FH535 is a dual inhibitor of Wnt/β-catenin and PPAR signaling, which may result in lower AIDA levels.

GSK-3 Inhibitor XVI

252917-06-9sc-221691
sc-221691A
5 mg
25 mg
$153.00
$520.00
4
(1)

A potent Wnt antagonist that could disrupt AIDA expression by inhibiting the Wnt/β-catenin signaling pathway.

CCT128930

885499-61-6sc-364459
sc-364459A
5 mg
10 mg
$153.00
$286.00
2
(1)

This small molecule is a Wnt/β-catenin pathway inhibitor that could theoretically downregulate AIDA.

Pyrvinium Pamoate

3546-41-6sc-476920A
sc-476920
250 mg
500 mg
$224.00
$414.00
(0)

An anthelmintic that can inhibit Wnt signaling, potentially affecting AIDA expression downstream.

Wnt-C59

1243243-89-1sc-475634
sc-475634A
sc-475634B
5 mg
10 mg
50 mg
$210.00
$320.00
$1250.00
1
(0)

LGK-974 is an inhibitor of Wnt production, which could subsequently decrease AIDA expression.